Race Oncology Embraces Corporate Governance Standards

Race Oncology Ltd. (AU:RAC) has released an update.

Race Oncology Limited has affirmed their commitment to robust corporate governance by disclosing full adherence to the ASX Corporate Governance Council’s recommendations for the financial year ended June 30, 2024. The company’s detailed corporate governance statement is accessible on their website, ensuring transparency for their shareholders and stakeholders. The board-approved statement, up-to-date as of August 27, 2024, can be found at https://www.raceoncology.com/investors/.

For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.